SEARCH

SEARCH BY CITATION

References

  • Allen, M., De Fusco, C., Legrand, F., Clementi, R., Conter, V., Danesino, C., Janka, G. & Arico, M. (2001) Familial hemophagocytic lymphohistiocytosis: how late can the onset be? Haematologica, 86, 499503.
  • Ambruso, D.R., Hays, T., Zwartjes, W.J., Tubergen, D.G. & Favara, B.E. (1980) Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16-213. Cancer, 45, 25162520.
  • Ardeshna, K.M., Hollifield, J., Chessells, J.M., Veys, P. & Webb, K.H. (2001) Outcome for children after failed transplant for primary haemophagocytic lymphohistiocytosis. British Journal of Haematology, 115, 949952.
  • Arico, M., Janka, G., Fischer, A., Henter, J.-I., Blanche, S., Elinder, G., Martinetti M. & Rusca M.P. (1996) Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. Leukemia, 10, 197203.
  • Arico, M., Imashuku, S., Clementi, R., Hibi, S., Teramura, T., Danesino, C., Haber, D. & Nichols, K.E. (2001) Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the x-linked lymphoproliferative disease gene. Blood, 97, 11311133.
  • Arico, M., Allen, M., Brusa, S., Clementi, R., Pende, D., Maccario, R., Moretta, L. & Danesino, C. (2002) Haemophagocytic lymphohistiocytosis: proposal of a diagnostic algorithm based on perforin expression. British Journal of Haematology, 119, 180188.
  • Bader-Meunier, B., Parez, N. & Muller, S. (2000) Treatment of hemophagocytic lymphohistiocytosis with cyclosporin A and steroids in a boy with lysinuric protein intolerance. Journal of Pediatrics, 136, 134.
  • Baker, K.S., DeLaat, C.A., Steinbuch, M., Gross, T.G., Shapiro, R.S., Loechelt, B., Harris, R. & Filipovich, A.H. (1997) Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation. Blood, 89, 38573863.
  • Bejaoui, M., Veber, F., Girault, D., Gaud, C., Blanche, S., Griscelli, C. & Fischer, A. (1989) The accelerated phase of Chediak–Higashi syndrome. Archives of French Pediatrics, 46, 733736.
  • Beutel, K., Janka, G.E. & Schneider, M.E. (2002) EBV-associated hemophagocytic lymphohistiocytosis (HLH) in German children. Medical and Pediatric Oncology, 38, 224.
  • Blanche, S., Caniglia, M., Fischer, A. & Griscelli, C. (1989) Epstein–Barr virus-associated hemophagocytic syndrome: clinical presentation and treatment. Pediatric Hematology and Oncology, 6, 233235.
  • Blanche, S., Caniglia, M., Girault, D., Landman, J., Griscelli, C. & Fischer, A. (1991) Treatment of hemophagocytic lymphohistiocytosis with chemotherapy and bone marrow transplantation: a single-centre study of 22 cases. Blood, 78, 5154.
  • Cemeroglu, A.P. & Özsoylu, S. (1994) Haematologic consequences of viral infections including serum iron status. European Journal of Pediatrics, 153, 171173.
  • Chen, J.-S., Lin, K.-H., Lin, D.-T., Chen, R.-L., Jou, S.-T. & Su, I.-J. (1998) Longitudinal observation and outcome of nonfamilial childhood haemophagocytic syndrome receiving etoposide-containing regimens. British Journal of Haematology, 103, 756762.
  • Clementi, R., Zur Stadt, U., Savoldi, G., Varotto, S., Conter, V., De Fusco, C., Notarangelo, L.D., Schneider, M., Klersy, C., Janka, G., Danesino, C. & Arico, M. (2001) Six novel mutations in the PRF1 gene in children with haemophagocytic lymphohistiocytosis. Journal of Medical Genetics, 38, 643646.
  • Clementi, R., Emmi, L., Maccario, R., Liotta, F., Moretta, L., Danesino, C. & Arico, M. (2002) Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood, 100, 22662267.
  • Dimitriou, H., Stiakaki, E., Markaki, E.-A., Bolonaki, I., Giannakopoulou, Ch. & Kalmanti, M. (2000) Soluble transferrin receptor levels and soluble transferrin receptor/log ferritin index in the evaluation of erythropoietic status in childhood infections and malignancy. Acta Paediatrica, 89, 11691173.
  • Dufourcq-Lagelouse, R., Pastural, E., Barrat, F.J., Feldmann, J., Le Deist, F., Fischer, A. & De Saint Basile, G. (1999) Genetic basis of hemophagocytic lymphohistiocytosis syndrome. International Journal of Molecular Medicine, 4, 127133.
  • Dürken, M., Horstmann, M., Bieling, P., Erttmann, R., Kabisch, H., Löliger, C., Schneider, E.M., Hellwege, H.-H., Krüger, W., Kröger, N., Zander, A.R. & Janka, G.E. (1999) Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single-centre experience of 12 patients. British Journal of Haematology, 106, 10521058.
  • Dürken, M., Graf Finckenstein, F. & Janka, G.E. (2001) Bone marrow transplantation in hemophagocytic lymphohistiocytosis. Leukemia and Lymphoma, 41, 8995.
  • Duval, M., Fenneteau, O., Doireau, V., Faye, A., Emilie, D., Yotnda, P., Drapier, J.-C., Schlegel, N., Sterkers, G., De Baulny, H.O. & Vilmer, E. (1999) Intermittent hemophagocytic lymphohistiocytosis is a regular feature of lysinuric protein intolerance. Journal of Pediatrics, 134, 236239.
  • Eife, R., Janka, G.E., Belohradsky, B.H. & Holtmann, H. (1989) Natural killer cell function and interferon production in familial hemophagocytic lymphohistiocytosis. Pediatric Hematology and Oncology, 6, 265272.
  • Emmenegger, U., Frey, U., Reimers, A., Fux, C., Semela, D., Cottagnoud, P., Spaeth, P. & Neftel, K. (2001) Hyperferritinemia as a indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. American Journal of Hematology, 68, 410.
  • Erduran, E., Gedik, Y., Sen, Y. & Yildiran, A. (2000) Successful treatment of reactive hemophagocytic syndrome with cyclosporin A and intravenous immunoglobulin. Turkish Journal of Pediatrics, 42, 168170.
  • Ericson, G.K., Fadeel, B., Nilsson-Ardnor, S., Söderhäll, C., Samuelsson, A.C., Janka, G., Schneider, M., Gürgey, A., Yalman, N., Revesz, T., Egeler, R.M., Jahnukainen, K., Storm-Mathiesen, I., Haraldsson, A., Poole, J., de Saint Basile, G., Nordenskjöld, M. & Henter, J.-I. (2001) Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. American Journal of Human Genetics, 68, 590597.
  • Farquhar, J.W. & Claireaux, A.E. (1952) Familial haemophagocytic reticulosis. Archives of Disease in Childhood, 27, 519525.
  • Feldmann, J., Le Deist, F., Ouachee-Chardin, M., Certain, S., Alexander, S., Quartier, P., Haddad, E., Wulffraat, N., Casanova, J.L., Blanche, S., Fischer, A. & de Saint Basile, G. (2002) Functional consequences of perforin gene mutation in 22 patients with familial haemophagocytic lymphohistiocytosis. British Journal of Haematology, 177, 965972.
  • Fischer, A., Virelizier, J.L., Arenzana-Seisdedos, F., Perez, N., Nezelof, C. & Griscelli, C. (1985) Treatment of four patients with erythrophagocytic lymphohistiocytosis by a combination of epipodophyllotoxin, steroids, intrathecal methotrexate, and cranial irradiation. Pediatrics, 76, 263268.
  • Fischer, A., Cerf-Bensussan, N., Blanche, S., Le Deist, F., Bremard-Oury, C., Leverger, G., Schaison, G., Durandy, A. & Griscelli, C. (1986) Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis. Journal of Pediatrics, 108, 267270.
  • Freeman, B., Rathore, M.H., Salman, E., Joyce, M.J. & Pitel, P. (1993) Intravenously administered immune globulin for the treatment of infection-associated hemophagocytic syndrome. Journal of Pediatrics, 123, 479481.
  • Fruman, D.A., Burakoff, S.J. & Bierer, B.E. (1994) Immunophilins in protein folding and immunosuppression. FASEB Journal, 8, 391400.
  • Galon, J., Franchimont, D., Hiroi, N., Frey, G., Boettner, A., Ehrhart-Bornstein, M., O'Shea, J.J., Chrousos, G.P. & Bornstein, S.R. (2002) Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB Journal, 16, 6171.
  • Garbagnati, E. (1993) Changes in lipid profile observed in children over the course of infection. Acta Paediatrica, 82, 948952.
  • Goulder, P., Seward, D. & Hatton, C. (1990) Intravenous immunoglobulin in virus associated haemophagocytic syndrome. Archives of Disease in Childhood, 65, 12751277.
  • Grom, A., Villaneuva, J., Lee, S., Goldmuntz, E.A., Passo, M.H. & Filipovich, A. (2003) Natural killer cell dysfunction in patients with systemic-onset juvenile rhematoid arthritis and macrophage activation syndrome. Journal of Pediatrics, 142, 292296.
  • Gurgey, A., Sayli, T., Kara, A., Kale, G. & Berkel, I. (1996) Treatment of X-linked lymphoproliferative disease (Duncan disease) with high-dose methylprednisolone and etoposide (VP-16). Turkish Journal of Pediatrics, 38, 271222.
  • Hadchouel, M., Prieur, A.-M. & Griscelli, C. (1985) Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. Journal of Pediatrics, 106, 561566.
  • Haddad, E., Sulis, M.-L., Jabado, N., Blanche, S., Fischer, A & Tardieu, M. (1997) Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood, 89, 794800.
  • Henter, J.-I. & Elinder, G. (1992) Cerebromeningeal haemophagocytic lymphohistiocytosis. Lancet, 339, 104107.
  • Henter, J.-I., Elinder, G., Söder, O., Hansson, M., Andersson, B. & Andersson, U. (1991a) Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood, 78, 29182922.
  • Henter, J.-I., Elinder, G. & Öst, A. (1991b) Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Seminars in Oncology, 18, 2933.
  • Henter, J.-I., Ehrnst, A., Andersson, J. & Elinder, G. (1993) Familial hemophagocytic lymphohistiocytosis and viral infections. Acta Pædiatrica, 82, 369372.
  • Henter, J.-I., Andersson, B., Elinder, G., Jakobson, A., Lübeck, P.-O. & Söder, O. (1996) Elevated circulating levels of interleukin-1 receptor antagonist but not IL-1 agonists in hemophagocytic lymphohistiocytosis. Medical and Pediatric Oncology, 27, 2125.
  • Henter, J.-I., Arico, M., Egeler, R.M., Elinder, G., Favara, B.E., Filipovich, A.H., Gadner, H., Imashuku, S., Janka-Schaub, G., Komp, D., Ladisch, S. & Webb, D. (1997) HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. Medical and Pediatric Oncology, 28, 342347.
  • Henter, J.-I., Samuelsson-Horne, A.C., Arico, M., Egeler, M.R., Elinder, G., Filipovich, A.H., Gadner, H., Imashuku, S., Komp, D., Ladisch, S., Webb, D. & Janka, G. (2002) Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood, 100, 23672373.
  • Ikeda, H., Kato, M., Matsunaga, A., Shimizu, Y., Katsuura, M. & Hayasaka, K. (1998) Multiple sulphatase deficiency and haemophagocytic syndrome. European Journal of Pediatrics, 157, 553554.
  • Imashuku, S. (1997) Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. International Journal of Hematology, 66, 135151.
  • Imashuku, S. (2002) Clinical features and treatment strategies of Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis. Critical Reviews in Oncology/Hematology, 44, 259272.
  • Imashuku, S., Hibi, S. & Todo, S. (1997) Hemophagocytic lymphohistiocytosis in infancy and childhood. Journal of Pediatrics, 130, 352357.
  • Imashuku, S., Hibi, S., Tabata, Y., Sako, M., Sekine, Y., Hirayama, K., Sakazaki, H., Maeda, N., Kito, H., Shichino, H. & Mugishima, H. (1998) Biomarker and morphological characteristics of Epstein–Barr virus-related hemophagocytic lymphohistiocytosis. Medical and Pediatric Oncology, 31, 131137.
  • Imashuku, S. Hibi, S., Todo, S., Sako, S., Inoue, M., Kawa, K., Koike, K., Iwai, A., Tsuchiya, S., Akiyama, Y., Kotani, T., Kawamura, Y., Hirosawa, M., Hasegawa, D., Kosaka, Y., Yamaguchi, H., Ishii, E., Kato, K., Ishii, M. & Kigasawa, H. (1999a) Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan. Bone Marrow Transplantation, 23, 569572.
  • Imashuku, S., Hibi, S., Ohara, T., Iwai, A., Sako, M., Kato, M., Arakawa, H., Sotomatsu, M., Kataoka, S., Asami, K., Hasegawa, D., Kosaka, Y., Kimihiko, S., Igarashi, N., Maruhashi, K., Ichimi, R., Kawasaki, H., Maeda, N., Tanizawa, A., Arai, K., Abe, T., Hisakawa, H., Miyashita, H. & Henter, J.-I. (1999b) Effective control of Epstein–Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Blood, 93, 18691874.
  • Imashuku, S., Kuriyama, K., Teramura, T., Ishii, E., Kinugawa, N., Kato, M., Sako, M. & Hibi, S. (2001) Requirement for etoposide in the treatment of Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis. Journal of Clinical Oncology, 19, 26652673.
  • Jabado, N., De Graeff-Meeder, E.R., Cavazzana-Calvo, M., Haddad, E., Le Deist, F., Benkerrou, M., Dufourcq, R., Caillat, S., Blanche, S. & Fischer, A. (1997) Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors. Blood, 90, 47434748.
  • Janka, G.E. (1983) Familial hemophagocytic lymphohistiocytosis. European Journal of Pediatrics, 140, 221230.
  • Janka, G.E. (1989) Familial hemophagocytic lymphohistiocytosis: therapy in the German experience. Pediatric Hematology and Oncology, 6, 227231.
  • Janka, G., Imashuku, S., Elinder, G., Schneider, M. & Henter, J.-I. (1998) Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematological and Oncological Clinics of North America, 12, 435444.
  • Janka, G.E., Müller-Rosenberger, M. & Schneider, E.M. (2000) Persistent defect of cellular cytotoxicity after Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis (HLH). Blood, 96, 36b.
  • Janka, G.E., Müller-Rosenberger, M., Schneider, E.M., Lorenz, J. & Henter, J.-I. (2001) Primary versus secondary hemophagocytic lymphohistiocytosis (HLH) – a relevant issue? Medical and Pediatric Oncology, 36, 417.
  • Janka-Schaub, G.E., Rosenberger, M., Lorenz, I. & Schneider, E.M. (1999) Hemophagocytic lymphohistiocytosis: clinical variability and usefulness of diagnostic parameters. Medical and Pediatric Oncology, 33, 517.
  • Jerome, K.R., Tait, J.F., Koelle, D.M. & Corey, L. (1998) Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis. Journal of Virology, 72, 436441.
  • Kawaguchi, H., Miyashita, T., Herbst, H., Niedobitek, G., Asada, M., Tsuchida, M., Hanada, R., Kinoshita, A., Sakurai, M., Kobayashi, N. & Mizutani, S. (1993) Epstein–Barr virus-infected T lymphocytes in Epstein–Barr virus associated hemophagocytic syndrome. Journal of Clinical Investigation, 92, 14441450.
  • Kikuta, H. & Sakiyama, Y. (1995) Etoposide (VP-16) inhibits Epstein–Barr virus determined nuclear antigen (EBNA) synthesis. British Journal of Haematology, 90, 971973.
  • Kogawa, K., Lee, S.M., Villanueva, J., Marmer, D., Sumegi, J. & Filipovich, A.H. (2002) Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood, 99, 6166.
  • Komp, D.M., McNamara, J. & Buckley, P. (1989) Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood, 73, 12282132.
  • Kumar, M., Sackey, K., Schmalstieg, F., Trizna, Z., Elghetany, T. & Alter, B.P. (2001) Griscelli syndrome: rare neonatal syndrome of recurrent hemophagocytosis. Journal of Pediatric Hematology/Oncology, 23, 464468.
  • Landman-Parker, J., Le Deist, F., Blaise, A., Brison, O. & Fischer, A. (1993) Partial engraftment of donor bone marrow cells associated with long-term remission of hemophagocytic lymphohistiocytosis. British Journal of Haematology, 85, 3741.
  • Larroche, C., Bruneel, F., Andre, M.-H., Bader-Meunier, B., Baruchel, A., Tribout, B., Genereau, T. & Zunic, P. (2000) Les immunoglobulines intra-veineuses dans les syndromes d'activation macrophagique secondaires. Annales de Medicine Interne, 151, 533539.
  • Loechelt, B.J., Egeler, M, Filipovich, A.H., Jyonouchi, H. & Shapiro, R.S. (1994) Immunosuppression: preliminary results of alternative maintenance therapy for familial hemophagocytic lymphohistiocytosis (FHL). Medical and Pediatric Oncology, 22, 325328.
  • Mandel, H., Gozal, D., Aizin, A., Tavori, S. & Jaffe, M. (1990) Haemophagocytosis in hereditary fructose intolerance: a diagnostic dilemma. Journal of Inherited Metabolic Disease, 13, 267269.
  • Mouy, R., Stephan, J.-L., Pillet, P., Haddad, E., Hubert, P. & Prieur, A.-M. (1996) Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. Journal of Pediatrics, 129, 751724.
  • Mroczek, E.C., Weisenburger, D.D., Lipscomb Grierson, H., Markin, R. & Purtilo, D.T. (1987) Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. Archives of Pathology and Laboratory Medicine, 111, 530535.
  • Ohadi, M., Lalloz, M.R.A., Sham, P., Zhao, J., Dearlove, A.M., Shiach, C., Kinsey, S., Rhodes, M. & Layton, D.M. (1999) Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3–22 by homozygosity mapping. American Journal of Human Genetics, 64, 165171.
  • Ohga, S., Nomura, A., Kai, T., Matsuzaki, A., Inaba, S., Suda, M. & Ueda, K. (1997) Prolonged resolution of hemophagocytic lymphohistiocytosis following myeloablative chemotherapy and subsequent autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation, 19, 633635.
  • Osugi, Y., Hara, J., Tagawa, S., Takai, K., Hosoi, G., Matsuda, Y., Ohta, H., Fujisaki, H., Kobayashi, M., Sakata, N., Kawa-Ha, K., Okada, S. & Tawa, A. (1997) Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood, 89, 41004103.
  • Parizhskaya, M., Reyes, J. & Jaffe, R. (1999) Hemophagocytic syndrome presenting as acute hepatic failure in two infants: clinical overlap with neonatal hemochromatosis. Pediatric and Developmental Pathology, 2, 360366.
  • Pelkonen, P., Swanljung, D. & Siimes, A. (1986) Ferritinemia as an indicator of systemic disease activity in children with systemic juvenile rheumatoid arthritis. Acta Paediatrica Scandinavica, 75, 6468.
  • Perez-Encinas, M., Villamyor, M., Campos, A., Gonzalez, S. & Bello, J.L. (1998) Tumor burden and serum level of soluble CD25, CD8, CD23, CD54 and CD44 in non-Hodgkin's lymphoma. Haematologica, 83, 752754.
  • Poggi, A., Costa, P., Tomasello, E. & Moretta, L. (1998) IL-12-induced up-regulation of NKRP1A expression in human NK cells and consequent NKRP1A-mediated down-regulation of NK cell activation. European Journal of Immunology, 28, 16111616.
  • Ramanan, A.V., Baildam, E.M. & Wynn, R.F. (2002) Macrophage activation syndrome is hemophagocytic lymphohistiocytosis – need for the right terminology. Journal of Rheumatology, 29, 115.
  • Reardon, D.A., Roskos, R., Hanson, C.A. & Castle, V. (1991) Virus-associated hemophagocytic syndrome following bone marrow transplantation. American Journal of Pediatric Hematology/Oncology, 13, 305309.
  • Reiner, A.P. & Spivak, J.L (1988) Hematophagic histiocytosis. Medicine, 67, 369388.
  • Risdall, R.J., McKenna, R.W., Nesbit, M.E., Krivit, W., Balfour, H.H., Simmons, R.L. & Brunning, R.D. (1979) Virus-associated hemophagocytic syndrome. Cancer, 44, 9931002.
  • Ross, C., Svenson, M., Nielsen, H., Lundsgaard, C., Hansen, M.B. & Bendtzen, K. (1997) Increased in vivo antibody activity against interferon γ, interleukin-1β, and interleukin-6 after high-dose Ig therapy. Blood, 90, 23762380.
  • Schneider, E.M., Lorenz, I., Müller-Rosenberger, M., Steinbach, G., Kron, M. & Janka-Schaub, G.E. (2002) Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis. Blood, 100, 28912898.
  • Schneider, E.M., Lorenz, I., Walther, P. & Janka-Schaub, G.E. (2003) Natural killer cell deficiency: a minor or major factor in the manifestation of hemophagocytic lymphohistiocytosis? American Journal of Pediatric Hematology/Oncology, 25, 680683.
  • Stephan, J.L., Donadieu, F., Ledeist, F., Blanche, S., Griscelli, C. & Fischer, A. (1993) Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A. Blood, 82, 23192323.
  • Stephan, J.L., Kone-Paut, I., Galambrun, C., Mouy, R., Bader-Meunier, B. & Prieur, A.-M. (2001) Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology, 40, 12851292.
  • Stepp, S.E., Dufourcq-Lagelouse, R., Le Deist, F., Bhawan, S., Certain, S., Mathew, P.A., Henter, J.-I., Bennet, M., Fischer, A., De Saint Basile, G. & Kumar, V. (1999) Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science, 286, 19571959.
  • Su, I.-J., Lin, D.-T., Hsieh, H.-C., Lee, S.-H., Chen, S.-J., Chen, R.-L., Lee, C.-Y. & Chen, J.-Y. (1990) Fatal primary Epstein–Barr virus infection masquerading as histiocytic medullary reticulosis in young children in Taiwan. Hematologic Pathology, 4, 189195.
  • Suga, N., Takada, H., Nomura, A., Ohga, S., Ishii, E., Ihara, K., Ohshima, K. & Hara, T. (2002) Perforin defects of primary haemophagocytic lymphohistiocytosis in Japan. British Journal of Haematology, 116, 346349.
  • Sullivan, K.E., Delaat, C.A., Douglas, S.D. & Filipovich, A.H. (1998) Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives. Pediatric Research, 44, 465468.
  • Teruya-Feldstein, J., Setsuda, J., Yao, X., Kingma, D.W., Straus, S., Tosato, G. & Jaffe, S. (1999) MIP-1α expression in tissues from patients with hemophagocytic syndrome. Laboratory Investigation, 79, 15831590.
  • Tsuji, Y., Ayaki, H., Whitman, S., Morrow, C.S., Torti, S.V. & Torti, F.M. (2000) Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress. Molecular and Cellular Biology, 20, 58185827.
  • Woltman, A.M., Massacrier, C., De Fijter, J.W., Caux, C. & Van Kooten, C. (2002) Corticosteroids prevent generation of CD34+-derived dermal dendritic cells but do not inhibit Langerhans cell development. Journal of Immunology, 168, 61816188.
  • Wulffraat, N.M., Rijkers, G.T., Elst, E., Brooimans, R. & Kuis, W. (2003) Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation. Rheumatology, 42, 375379.
  • Yu, Y., Hagihara, M., Ando, K., Gansuvd, B., Matsuzawa, H., Tsuchiya, T., Ueda, Y., Inoue, H., Hotta, T. & Kato, S. (2001) Enhancement of human cord blood CD32+ cell-derived NK cell cytotoxicity by dendritic cells. Journal of Immunology, 166, 15901600.
  • Zur Stadt, U., Pruggmayer, M., Jung, H., Henter, J.-I., Schneider, M., Kabisch, H. & Janka, G. (2002) Prenatal diagnosis of perforin gene mutations in familial hemophagocytic lymphohistiocytosis (FHLH). Prenatal Diagnosis, 22, 7782.